Novel methods to estimate antiretroviral adherence: protocol for a longitudinal study

References

• ChesneyMAThe elusive gold standard. Future perspectives for HIV adherence assessment and interventionJ Acquir Immune Defic Syndr200643Suppl 1S149S15517133199
   PubMed Web of Science ®Google Scholar
• World Health OrganizationAdherence to Long-Term Therapies: Evidence for ActionGenevaWorld Health Organization2003
   Google Scholar
• CohenMSChenYQMcCauleyMHPTN 052 Study TeamPrevention of HIV-1 infection with early antiretroviral therapyN Engl J Med2011365649350521767103
   PubMed Web of Science ®Google Scholar
• BergKMArnstenJHPractical and conceptual challenges in measuring antiretroviral adherenceJ Acq Imm Def200643S79S87
   PubMed Web of Science ®Google Scholar
• KageeANelAAssessing the association between self-report items for HIV pill adherence and biological measuresAids Care201224111448145222670758
   PubMed Web of Science ®Google Scholar
• DuongMPirothLPeytavinGValue of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic responseClin Infect Dis200133338639211438909
   PubMed Web of Science ®Google Scholar
• BrambillaDJenningsCAldrovandiGMulticenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stabilityJ Clin Microbiol20034151888189312734222
   PubMed Web of Science ®Google Scholar
• CassolSSalasTGillMJStability of dried blood spot specimens for detection of human-immunodeficiency-virus DNA by polymerase chain-reactionJ Clin Microbiol19923012303930421452682
   PubMed Web of Science ®Google Scholar
• KumarAKRamachandranGKumarPKumaraswamiVSwaminathanSCan urine lamivudine be used to monitor antiretroviral treatment adherence?MedGenMed20068453
   Google Scholar
• GandhiMGreenblattRMHair it is: the long and short of monitoring antiretroviral treatmentAnn Intern Med2002137869669712379072
   PubMed Web of Science ®Google Scholar
• GandhiMAmeliNBacchettiPAtazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapyClin Infect Dis201152101267127521507924
   PubMed Web of Science ®Google Scholar
• LiuHGolinCEMillerLGA comparison study of multiple measures of adherence to HIV protease inhibitorsAnn Intern Med20011341096897711352698
   PubMed Web of Science ®Google Scholar
• WalshJCMandaliaSGazzardBGResponses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcomeAids200216226927711807312
   PubMed Web of Science ®Google Scholar
• HugenPWLangebeekNBurgerDMAssessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoringJ Acquir Immune Defic Syndr200230332433412131570
   PubMed Web of Science ®Google Scholar
• SaberiPCaswellNAmodio-GrotonMAlpertPPharmacy-refill measure of adherence to efavirenz can predict maintenance of HIV viral suppressionAids Care200820674174518576177
   PubMed Web of Science ®Google Scholar
• GrossbergRZhangYWGrossRA time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIVJ Clin Epidemiol200457101107111015528063
   PubMed Web of Science ®Google Scholar
• DiClementeRJRuizMSSalesJMBarriers to adolescents’ participation in HIV biomedical prevention researchJ Acquir Immune Defic Syndr201054S12S1720571418
   PubMed Web of Science ®Google Scholar
• LuMSafrenSASkolnikPROptimal recall period and response task for self-reported HIV medication adherenceAIDS Behav2008121869417577653
   PubMed Web of Science ®Google Scholar
• Panel on Antiretroviral Guidelines for Adults and AdolescentsGuidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human ServicesGuidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents2016 Available from: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdfAccessed September 10, 2017
   Google Scholar
• AmicoKRFisherWACornmanDHVisual analog scale of ART adherence: association with 3-day self-report and adherence barriersJ Acquir Immune Defic Syndr200642445545916810111
   PubMed Web of Science ®Google Scholar
• ChesneyMAIckovicsJRChambersDBSelf-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG)Aids Care200012325526610928201
   PubMed Web of Science ®Google Scholar
• SaberiPYuanPJohnMSheonNJohnsonMOA pilot study to engage and counsel HIV-positive African American youth via telehealth technologyAIDS Patient Care STDS201327952953223991691
   PubMed Web of Science ®Google Scholar
• BeumerJHBosmanIJMaesRHair as a biological specimen for therapeutic drug monitoringInt J Clin Pract200155635335711501221
   PubMed Web of Science ®Google Scholar
• GandhiMGreenblattRMBacchettiPA single-nucleotide polymorphism in CYP2B6 leads to > 3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected womenJ Infect Dis201220691453146122927450
   PubMed Web of Science ®Google Scholar
• GandhiMYangQYBacchettiPHuangYShort communication: a low-cost method for analyzing nevirapine levels in hair as a marker of adherence in resource-limited settingsAids Res Hum Retrov20143012528
   Web of Science ®Google Scholar
• BaxiSMLiuABacchettiPComparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measuresJ Acquir Immune Defic Syndr20146811320
   Web of Science ®Google Scholar
• HickeyMDSalmenCRTesslerRAAntiretroviral concentrations in small hair samples as a feasible marker of adherence in rural KenyaJ Acquir Immune Defic Syndr201466331131524694932
   PubMed Web of Science ®Google Scholar
• GandhiMAmeliNBacchettiPWomen’s Interagency HIV Study (WIHS)Protease inhibitor levels in hair strongly predict virologic response to treatmentAids200923447147819165084
   PubMed Web of Science ®Google Scholar
• van ZylGUvan MensTEMcIlleronHLow lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited settingJ Acquir Immune Defic Syndr201156433333921239995
   PubMed Web of Science ®Google Scholar
• BaxiSMGreenblattRMBacchettiPWomen’s Interagency HIV Study (WIHS)Nevirapine concentration in hair samples is a strong predictor of virologic suppression in a prospective cohort of HIV-infected patients10(6):e0129100.
   Google Scholar
• HuangYGandhiMGreenblattRMGeeWNLinETMessenkoffNSensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometryRapid Commun Mass Sp2008222134013409
   Web of Science ®Google Scholar
• HuangYYangQYYoonKMicroanalysis of the antiretroviral nevirapine in human hair from HIV-infected patients by liquid chromatography-tandem mass spectrometryAnal Bioanal Chem201140161923193321847531
   PubMed Web of Science ®Google Scholar
• GandhiMMwesigwaJAweekaFPrevention of Malaria and HIV disease in Tororo (PROMOTE) studyHair and plasma data show that lopinavir, ritonavir, and efavirenz all transfer from mother to infant in utero, but only efavirenz transfers via breastfeedingJ Acquir Immune Defic Syndr201363557858424135775
   PubMed Web of Science ®Google Scholar
• LiuAYYangQYHuangYStrong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP)PLoS One201491e8373624421901
   PubMed Web of Science ®Google Scholar
• OldsPKKiwanukaJPNanseraDAssessment of HIV anti-retroviral therapy adherence by measuring drug concentrations in hair among children in rural UgandaAids Care201527332733225483955
   PubMed Web of Science ®Google Scholar
• BartelinkIHSavicRMMwesigwaJPharmacokinetics of lopinavir/ritonavir and efavirenz in food insecure HIV-infected pregnant and breastfeeding women in Tororo, UgandaJ Clin Pharmacol201454212113224038035
   PubMed Web of Science ®Google Scholar
• CohanDNatureebaPKossCAEfficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan womenAids201529218319125426808
   PubMed Web of Science ®Google Scholar
• GandhiMGliddenDVLiuAStrong correlation between concentrations of tenofovir (TFV) emtricitabine (FTC) in hair and TFV diphosphate and FTC triphosphate in dried blood spots in the iPrEx open label extension: implications for pre-exposure prophylaxis adherence monitoringJ Infect Dis201521291402140625895984
   PubMed Web of Science ®Google Scholar
• KossCANatureebaPMwesigwaJHair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan womenAids201529782583025985404
   PubMed Web of Science ®Google Scholar
• SaberiPNeilandsTBMingKStrong correlation between concentrations of antiretrovirals in home-collected and study-collected hair samples: implications for adherence monitoringJ Acquir Immune Defic Syndr2017764e101e10328657913
   PubMed Web of Science ®Google Scholar
• YangQYLiuAYGandhiMGreenblattRMGeeWHuangYLC/LC/MS assay of tenofovir in human hair for pre-exposure prophylaxisPaper presented at: Association of Pharmaceutical Sciences (AAPS) Annual Meeting2010New Orleans, LA
   Google Scholar
• LiuAVittinghoffEGandhiMValidating measures of tenofovir drug exposure in a U.S. pre-exposure prophylaxis trialPaper presented at: 17th Conference on Retroviruses and Opportunistic Infections (CROI)2010San Francisco, CA
   Google Scholar
• GandhiMAmeliNBacchettiPConcentrations of efavirenz in hair are strongly correlated with virologic response (Paper 692)Paper presented at: 16th Conference on Retroviruses and Opportunistic Infections (CROI)2009Montreal, Canada
   Google Scholar
• BaxiSMGreenblattRMBacchettiPNevirapine concentrations in hair is a strong predictor of virologic suppression and toxicitiesPLoS One2015106e012910026053176
   PubMed Web of Science ®Google Scholar
• DiFrancescoRTooleyKRosenkranzSLClinical pharmacology quality assurance for HIV and related infectious diseases researchClin Pharmacol Ther201393647948223588323
   PubMed Web of Science ®Google Scholar
• LiuAGandhiMBacchettiPValidating hair as a biological marker of tenofovir drug exposure in HIV pre-exposure prophylaxis (PrEP)Paper presented at: 18th Conference on Retroviruses and Opportunistic Infections (CROI)2011Boston, MABoston, MA
   Google Scholar
• KalichmanSCAmaralCMCherryCMonitoring medication adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validityHIV Clin Trials20089529830818977718
   PubMed Web of Science ®Google Scholar
• KalichmanSCAmaralCMStearnsHAdherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephoneJ Gen Intern Med20072271003100617390095
   PubMed Web of Science ®Google Scholar
• MilesMBHubermanAMQualitative Data Analysis: An Expanded Sourcebook2nd edThousand Oaks, CASage Publications1994
   Google Scholar
• HessLMRaebelMAConnerDAMaloneDCMeasurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measuresAnn Pharmacother2006407–81280128816868217
   PubMed Web of Science ®Google Scholar
• BangsbergDRHechtFMCharleboisEDChesneyMMossAComparing objective measures of adherence to HIV antiretroviral therapy: electronic medication monitors and unannounced pill countsAids Behav200153275281
   Google Scholar
• NeuhausJMKalbfleischJDBetween- and within-cluster covariate effects in the analysis of clustered dataBiometrics19985426386459629647
   PubMed Web of Science ®Google Scholar
• AllisonPFixed Effects Regression Methods for Longitudinal Data Using SASCary, NCSAS Institute2005
   Google Scholar
• CarpenterJRKenwardMGWhiteIRSensitivity analysis after multiple imputation under missing at random: a weighting approachStat Methods Med Res200716325927517621471
   PubMed Web of Science ®Google Scholar